Captrust Financial Advisors Sells 122,218 Shares of CVS Health Co. (NYSE:CVS)

Captrust Financial Advisors decreased its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 23.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 402,346 shares of the pharmacy operator's stock after selling 122,218 shares during the quarter. Captrust Financial Advisors' holdings in CVS Health were worth $25,299,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the stock. Cetera Investment Advisers raised its stake in CVS Health by 190.9% in the 1st quarter. Cetera Investment Advisers now owns 407,844 shares of the pharmacy operator's stock valued at $32,530,000 after acquiring an additional 267,664 shares during the period. Cetera Advisors LLC raised its stake in CVS Health by 13.3% in the 1st quarter. Cetera Advisors LLC now owns 123,884 shares of the pharmacy operator's stock valued at $9,881,000 after acquiring an additional 14,551 shares during the period. EverSource Wealth Advisors LLC raised its stake in CVS Health by 27.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 13,865 shares of the pharmacy operator's stock valued at $1,106,000 after acquiring an additional 2,970 shares during the period. Transcend Capital Advisors LLC raised its stake in CVS Health by 27.1% in the 2nd quarter. Transcend Capital Advisors LLC now owns 22,639 shares of the pharmacy operator's stock valued at $1,337,000 after acquiring an additional 4,826 shares during the period. Finally, Park Place Capital Corp raised its stake in CVS Health by 18.1% in the 2nd quarter. Park Place Capital Corp now owns 2,033 shares of the pharmacy operator's stock valued at $120,000 after acquiring an additional 311 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on CVS shares. Evercore ISI increased their price target on CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a research note on Tuesday, October 8th. Mizuho lowered their price objective on CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research report on Thursday, October 24th. UBS Group increased their price objective on CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a research report on Thursday, November 7th. Barclays lowered their price objective on CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research report on Thursday, November 7th. Finally, TD Cowen increased their target price on CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a report on Monday, November 25th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and an average target price of $70.33.

CVS Health Price Performance

NYSE:CVS traded down $0.11 during trading hours on Friday, hitting $59.85. The company's stock had a trading volume of 3,947,743 shares, compared to its average volume of 11,314,412. The stock has a fifty day simple moving average of $59.36 and a 200-day simple moving average of $58.75. The company has a market capitalization of $75.32 billion, a P/E ratio of 15.19, a PEG ratio of 1.02 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a twelve month low of $52.71 and a twelve month high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same period last year, the firm posted $2.21 earnings per share. The business's revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts anticipate that CVS Health Co. will post 5.37 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.44%. The ex-dividend date was Monday, October 21st. CVS Health's payout ratio is 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.